K
Ken Takezawa
Researcher at Vanderbilt University
Publications - 1
Citations - 606
Ken Takezawa is an academic researcher from Vanderbilt University. The author has contributed to research in topics: Cetuximab & Afatinib. The author has an hindex of 1, co-authored 1 publications receiving 556 citations.
Papers
More filters
Journal ArticleDOI
HER2 amplification: a potential mechanism of acquired resistance to EGFR inhibition in EGFR-mutant lung cancers that lack the second-site EGFRT790M mutation.
Ken Takezawa,Valentina Pirazzoli,Maria E. Arcila,Caroline A. Nebhan,Xiaoling Song,Elisa de Stanchina,Kadoaki Ohashi,Yelena Y. Janjigian,Paula J. Spitzler,Mary Ann Melnick,G. J. Riely,Mark G. Kris,Vincent A. Miller,Marc Ladanyi,Katerina Politi,William Pao +15 more
TL;DR: It is shown in vitro and in vivo that afatinib plus cetuximab significantly inhibits HER2 phosphorylation, and this results reveal a previously unrecognized mechanism of resistance to EGFR-TKIs and provide a rationale to assess the status and possibly target HER2 in EG FR-mutant tumors with acquired resistance toEGFR- TKIs.